Home » Authors » Brady Huggett

Articles by Brady Huggett

Genentech Meets Estimates On Increased Rituxan Revenue

Jan. 17, 2003

By Brady Huggett

Genentech Meets Estimates On Increased Rituxan Revenue

Jan. 17, 2003

By Brady Huggett

Incara Making Sacrifices; Elan Declines Antioxidant Option

Jan. 16, 2003

By Brady Huggett

Incara Making Sacrifices; Elan Declines Antioxidant Option

Jan. 16, 2003

By Brady Huggett

Amylin Files For $141.7M Public Offering From Shelf

Jan. 14, 2003

By Brady Huggett

Amylin Files For $141.7M Public Offering From Shelf

Jan. 14, 2003

By Brady Huggett

ZymoGenetics, Novo Agree On $11M IL-21 Collaboratio

Jan. 10, 2003

By Brady Huggett

ZymoGenetics, Novo Agree On $11M IL-21 Collaboratio

Jan. 10, 2003

By Brady Huggett

Atrix Licenses Japanese Eligard Rights To Sosei In $30M Deal

Jan. 7, 2003

By Brady Huggett

DrugAbuse Sciences' Product Shows Benefit In Phase III Trial

Jan. 7, 2003

By Brady Huggett

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...